Both in Biotechnology
Fennec Pharmaceuticals vs C4 Therapeutics
Over the past year FENC returned +22.9% and CCCC returned +37.0%; their daily moves had a correlation of 0.23.
FENC +22.9% CCCC +37.0%Growth of $1, one year, split-adjusted
| Metric | FENC | CCCC |
|---|---|---|
| Price | $10.24 | $3.37 |
| Market cap | $359.1M | $414.6M |
| Today | −6.48% | +2.12% |
| 1 month | −0.9% | +7.3% |
| 6 months | +56.6% | +15.4% |
| Year to date | +33.0% | +76.4% |
| 1 year | +20.9% | +34.3% |
| Revenue growth (YoY) | +85.2% | +2.8% |
| Gross margin | 96.0% | 100.0% |
| Net margin | 11.0% | −355.9% |
| P/E (TTM) | — | — |
| Price / sales | 6.1× | 11.8× |
| Net cash | $41.2M | $253.7M |
| Dividend yield | — | — |
| Volatility (60d) | 57.5% | 65.1% |
| Short % of float | 2.2% | 43.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).